Program will explore recent accomplishments and trends in the biotechnology industry
A program titled "Bridging the Gap between Academia and Industry" will be presented on Friday, Sept. 20, by the Yale Biotechnology Student Interest Group, a multidisciplinary organization interested in promoting local biotechnology development.
The event, the Second Annual Yale and New Haven Biotechnology Reception, will take place at 12:30 p.m. at the New Haven Lawn Club, 193 Whitney Ave.
The program will highlight recent accomplishments of local companies and look at nationwide trends in biotechnology and the drug development industry. The conference also will explore issues related to the process by which new technologies are brought from the bench to the bedside.
There will be two keynote speakers: Dr. Stanley Crooke, founder, chair and chief executive officer (CEO) of Isis Pharmaceuticals, who is widely regarded as a pioneer in the biotechnology industry, and William Rice, founder and CEO of Achillion Pharmaceuticals. Their talks will be followed by a panel discussion addressing the biotech start-up process with perspectives from biotech management, venture capital, intellectual property law, and academia.
The complete agenda and registration information can be found at www.yale.edu/biotech/reception2002/agenda.html. The conference is free of charge, but registration is required since space is limited.
The Yale Biotechnology Student Interest Group (also known as the "Biotech SIG") was founded in 1998 by graduate students from Yale's law, medicine and business schools. Today the organization boasts over 500 Yale graduate and professional students.
The Biotech SIG has developed an interdisciplinary curriculum in life science business, which members hope to make available to Yale graduate students and postdoctoral fellows. The curriculum includes three courses spanning a full academic year. In the fall term, students would learn about technologies, their applications and implications for drug discovery. The spring term would be broken into two shorter courses, one devoted to strategic business issues in biotechnology and pharmaceuticals, and the other focusing on ethical and policy issues in life science business. The curriculum development team, which includes both students and faculty members, is currently refining the curriculum and devising a plan for successful implementation.
The Biotech SIG also draws on the skills of students from across the graduate and professional schools to provide consulting services to New Haven biopharmaceutical companies. These projects allow students to gain experience with real-world strategic problems, promote the growing New Haven biotechnology industry, and offer networking opportunities for Yale students and members of the New Haven biotechnology community.
The organization also hosts an investment analysis group that provides students with an opportunity to analyze ongoing biotechnology concerns and start-ups from stock analysis and private equity perspectives. Interdisciplinary teams deliver reports reflecting diverse viewpoints and insights on the scientific, marketing, regulatory and financial issues that affect success and valuation for biotechnology companies. The group seeks mentors in the financial and investment industries.
The Biotech SIG also sponsors a speakers series, which brings noted individuals from the biopharmaceutical industry to the Yale campus each year, as well as a career fair.
For more information, contact Chau Khuong (chau.khuong@yale.edu) or Rishi Gupta (rishi.gupta@yale.edu) or visit the group's website at www.yalebiotech.org.
T H I SW E E K ' SS T O R I E S
Yale to honor life of Edward Bouchet
ENDOWED PROFESSORSHIPS
Bulletin Home|Visiting on Campus|Calendar of Events|In the News|Bulletin Board
|